ITM2B and occult macular dystrophy: The results showed that tunicamycin treatment significantly elevated the mRNA expressions of these fibrosis markers, and the changes were reduced with different concentrations of BRI, LAT, or OMD cotreatment significantly compared to the tunicamycin-treated group in human TM cells.